Kyowa Pharmaceutical Detects Nitrosamine Impurities in Antidepressants, No Recall Issued

Kyowa Pharmaceutical Industry has identified nitrosamine impurities in its antidepressant medications, sertraline and maprotiline. Despite the detection, the company stated it would not initiate a voluntary recall because the impurity levels remain below established interim control limits. This situation highlights ongoing pharmaceutical quality control efforts and regulatory thresholds for drug safety.